A Study of TG103 in Subjects With Type 2 Diabetes

NCT04790006 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: TG103
DRUG: Placebo

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.